Preclinical News and Research

RSS
Moderate caloric intake may reduce risk of obesity in low-birth weight offspring

Moderate caloric intake may reduce risk of obesity in low-birth weight offspring

New data demonstrates anti-cancer activities of Oncoprex

New data demonstrates anti-cancer activities of Oncoprex

New preclinical data on ARIAD's ponatinib and AP26113 study presented at AACR meeting

New preclinical data on ARIAD's ponatinib and AP26113 study presented at AACR meeting

PolyTherics, Spirogen enter research collaboration to produce novel ADCs for treatment of cancer

PolyTherics, Spirogen enter research collaboration to produce novel ADCs for treatment of cancer

Nektar commences dosing in NKTR-192 Phase 1 clinical study for treatment of acute pain

Nektar commences dosing in NKTR-192 Phase 1 clinical study for treatment of acute pain

Ampio, Australian TGA reach agreement over Zertane submission plan

Ampio, Australian TGA reach agreement over Zertane submission plan

Blocking PRC2 protein may help protect against AML

Blocking PRC2 protein may help protect against AML

RT3D may boost effects of two standard chemotherapy drugs in head and neck cancer patients

RT3D may boost effects of two standard chemotherapy drugs in head and neck cancer patients

Bruker acquires SkyScan

Bruker acquires SkyScan

Metformin prevents primary liver cancer in animal models

Metformin prevents primary liver cancer in animal models

Dyax, GE Healthcare partner to develop and commercialize c-Met imaging peptides

Dyax, GE Healthcare partner to develop and commercialize c-Met imaging peptides

Galectin Therapeutics fourth quarter net loss increases to $3.7 million

Galectin Therapeutics fourth quarter net loss increases to $3.7 million

ImmunoGen commences IMGN901 Phase II evaluation for SCLC

ImmunoGen commences IMGN901 Phase II evaluation for SCLC

AlphaCore Pharma commences ACP-501 Phase 1 study in coronary arterial disease

AlphaCore Pharma commences ACP-501 Phase 1 study in coronary arterial disease

Daiichi Sankyo, NGM to discover and develop new treatments for diabetes

Daiichi Sankyo, NGM to discover and develop new treatments for diabetes

UTHealth, PLx Pharma to test phosphatidylcholine-enriched version of indomethacin in PDA model

UTHealth, PLx Pharma to test phosphatidylcholine-enriched version of indomethacin in PDA model

BioSeek, Merck Serono sign new BioMAP collaboration agreement

BioSeek, Merck Serono sign new BioMAP collaboration agreement

DSMB recommends Bionovo to continue Menerba Phase 3 trial for hot flashes

DSMB recommends Bionovo to continue Menerba Phase 3 trial for hot flashes

Althea provides Allena exclusive worldwide rights to broad hyperoxaluria portfolio

Althea provides Allena exclusive worldwide rights to broad hyperoxaluria portfolio

Nature journal publishes first volume of Cancer Cell Line Encyclopedia

Nature journal publishes first volume of Cancer Cell Line Encyclopedia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.